Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

• Status: Completed
• Trial end date: 2006-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to evaluate intravitreal injection of triamcinolone acetonide after laser panretinal photocoagulation in the treatment of proliferative diabetic retinopathy.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Sao Paulo
• Collaborator: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
• Treatments: Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• Type II Diabetes

• symmetric proliferative diabetic retinopathy without high risk characteristics

• Informed consent signed

Exclusion Criteria:

• previous treatment for diabetic retinopathy

• media opacities that may interfere with clinical, photographically or OCT examinations

• inability to understands the implications of the protocol

• Glaucoma or ocular hypertension

• Any other pathology that could cause retinal alterations

• Patients with any other situation that may interfere in study completion based in Investigator´s opinion